Promising Technology for Biotechnology and Pharmaceutical Industries

In this 2019 paper, Crommelin et al. discuss the changing landscape of biologics and pharmaceutical formulation, analytical methods, immunogenicity and quality control. They specifically discuss the technology behind ParticleSentryᴬᴵ and acknowledge the promise our approach demonstrates.

The paper acknowledges the progress made overall in the industry since their last review in 2003 and calls for more predictive approaches to immunogenicity, quality assurance and recommends the use of analytical tools and methods to deliver batch-to-batch consistency to improve patient outcomes.



Leave a Reply

Your email address will not be published. Required fields are marked *